Simcere Pharmaceutical Group (SCR) is Dedicated to Innovative Research and Development
Simcere Pharmaceutical Group is furthering its position in the rapidly growing China market. Headquartered in Nanjing, China, it is a manufacturer and supplier of branded generic and innovative anti-cancer pharmaceuticals. As part of the Drug Manufacturing industry, it concentrates research and development on the treatment of diseases with high incidences and/or mortality rates. Shares trade on the New York Stock Exchange. Simcere is focusing on drug medications for cancer, strokes, infectious diseases, and osteoporosis. They have introduced an anti-stroke medication under the brand name Bicun. They have also introduced an anti-cancer medication under the brand name Endu. The company makes…